|
|
 |
|
|
|
|
News
HEMARINA expands its operations to Boston U.S.A. Hemarina Inc. will be the company affiliate for the America
HEMARINA, the French based Biotechnology Company, today announced its establishment in Boston, Massachusetts USA thru the incorporation of Hemarina Inc. on March 15th, 2013. The new affiliate will be... More + |
HEMARINA raises €6.3 Million in Series B Funding
This financing will help Hemarina bring to market its first product in the field of organ transplant, and will also strengthen its infrastructure as well as its R&D programs.
Morlaix,... More + |
ANR selects Hemarina’s HEMO2Perf® project
Morlaix, Brittany, Novembre 7th, 2011 - The French National Research Agency is to fund the HEMO2Perf® project, demonstrating once again the scientific and therapeutic interest in the oxygen... More + |
|
|
|
Corporate
|
Technology & Products
|
Intellectual Property
|
Investors |
News & Media
|
 |
>> Company Overview
>> Managment Team
>> Board of Directors
>> Scientific and Ethics Board
>> Hemarina Label and Public Funding
|
|
>> Organ Preservation
>> Wound Healing
>> Hemoglobin Oxygen-Carrier
>> Cell Culture and Bioproduction
>> Other Perspective
|
|
>> Portfolio
>> Literature References
|
|
|
|
>> News
>> Hemarina Awards
>> Press Releases
>> Video Releases
>> 2013
|
|
|
